EchoIQ shares plunged 60% after the FDA issued an NSE notice blocking its heart-failure AI product from the US market. Despite panic selling, strong cash reserves, an active second product, and a management options grant suggest this is a regulatory setback, not a financial collapse.
.webp&w=828&q=75)
Titomic (ASX: TTT) shares rallied after a US$5 million Air Force contract, following a $16.5 million placement. The advanced manufacturer, still loss-making, is progressing a US redomiciliation while shares test key support with a potential trendline breakout ahead.
Global markets remained volatile as persistent inflation and geopolitical tensions reduced expectations of near-term Federal Reserve rate cuts. In Australia, high living costs, elevated fuel prices, weak consumer sentiment, and mortgage stress continue to constrain domestic demand, while the RBA maintains a cautious higher-for-longer policy stance.
St Barbara is reshaping its business through the proposed Simberi sale, stronger cash reserves and a sharper focus on Nova Scotia. The Touquoy restart, 15-Mile project, royalty exposure and potential capital returns now define the company’s next phase.
Resolution Minerals (ASX/Nasdaq: RML) commenced trading ADRs on Nasdaq to attract US institutional capital and federal support for its Idaho Horse Heaven critical minerals project, leveraging dual FAST-41 permitting status across its key antimony, tungsten, and gold prospects.
BPM Minerals (ASX: BPM) is drilling its flagship Forelands Gold Project, targeting a maiden resource at Beachcomber. Shares broke out above $0.24 on strong volume, though the stock remains a speculative early-stage explorer dependent on upcoming assay results.
